Harmony Biosciences Holdings Shares Outstanding 2020-2021 | HRMY

Harmony Biosciences Holdings shares outstanding from 2020 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Harmony Biosciences Holdings Annual Shares Outstanding
(Millions of Shares)
2020 26
2019 8
Harmony Biosciences Holdings Quarterly Shares Outstanding
(Millions of Shares)
2021-06-30 59
2021-03-31 59
2020-12-31 26
2020-09-30 30
2020-06-30 8
2020-03-31 8
2019-09-30 8
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.197B $0.160B
Harmony Biosciences Holdings Inc.is a pharmaceutical company. It engages in developing and commercializing therapies for rare neurological disorders. Harmony Biosciences Holdings Inc.is based in Plymouth Meeting, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71